Højlund M - Search Results

1

Association of Low-Dose Quetiapine and Diabetes.

Højlund M, Lund LC, Andersen K, Correll CU, Hallas J. Højlund M, et al. JAMA Netw Open. 2021 May 3;4(5):e213209. doi: 10.1001/jamanetworkopen.2021.3209. JAMA Netw Open. 2021. PMID: 33961038 Free PMC article.

2

Changes in antipsychotics and other psychotropic drugs during a 30-month lifestyle intervention among outpatients with schizophrenia.

Højlund M, Elliott AF, Madsen NJ, Viuff AG, Munk-Jørgensen P, Hjorth P. Højlund M, et al. Nord J Psychiatry. 2017 Nov;71(8):598-604. doi: 10.1080/08039488.2017.1365379. Epub 2017 Aug 24. Nord J Psychiatry. 2017. PMID: 28836471

3

Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016.

Højlund M, Pottegård A, Johnsen E, Kroken RA, Reutfors J, Munk-Jørgensen P, Correll CU. Højlund M, et al. Br J Clin Pharmacol. 2019 Jul;85(7):1598-1606. doi: 10.1111/bcp.13945. Epub 2019 May 11. Br J Clin Pharmacol. 2019. PMID: 30927284 Free PMC article.

4

Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study.

Højlund M, Lund LC, Herping JLE, Haastrup MB, Damkier P, Henriksen DP. Højlund M, et al. BMJ Open. 2020 Aug 11;10(8):e038247. doi: 10.1136/bmjopen-2020-038247. BMJ Open. 2020. PMID: 32784262 Free PMC article.

5

How to Estimate QT Interval in Patients With Left or Right Bundle Branch Block: A Systematic Review.

Fredholm K, Højlund M, Bjerregaard MR, Nielsen JC, Fink-Jensen A, Correll CU. Fredholm K, et al. Among authors: hojlund m. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):323-326. doi: 10.1097/JCP.0000000000001373. J Clin Psychopharmacol. 2021. PMID: 33657070

6

Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses.

Højlund M, Andersen JH, Andersen K, Correll CU, Hallas J. Højlund M, et al. Epidemiol Psychiatr Sci. 2021 Apr 6;30:e28. doi: 10.1017/S2045796021000159. Epidemiol Psychiatr Sci. 2021. PMID: 33820580 Free PMC article.

7

Sodium-glucose cotransporter-2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis.

Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB. Lund LC, et al. Among authors: hojlund m. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1391-1395. doi: 10.1002/pds.5252. Epub 2021 May 13. Pharmacoepidemiol Drug Saf. 2021. PMID: 33881179

8

Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.

Højlund M, Kemp AF, Haddad PM, Neill JC, Correll CU. Højlund M, et al. Lancet Psychiatry. 2021 Jun;8(6):471-486. doi: 10.1016/S2215-0366(21)00078-X. Lancet Psychiatry. 2021. PMID: 34023019

9

Withdrawal-associated relapse is a potential source of bias - Authors' reply.

Højlund M, Kemp AF, Haddad PM, Neill JC, Correll CU. Højlund M, et al. Lancet Psychiatry. 2021 Sep;8(9):748-749. doi: 10.1016/S2215-0366(21)00288-1. Lancet Psychiatry. 2021. PMID: 34419176 No abstract available.

10

RE: Gout and sodium-glucose cotransporter-2 inhibitors.

Lund LC, Højlund M, Henriksen DP, Hallas J, Kristensen KB. Lund LC, et al. Among authors: hojlund m. Pharmacoepidemiol Drug Saf. 2022 Jan;31(1):114-115. doi: 10.1002/pds.5380. Epub 2021 Nov 14. Pharmacoepidemiol Drug Saf. 2022. PMID: 34729863 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters